Mutations causing loss of function in VHL, an E3 ligase, result in tumoral development, especially renal cell carcinoma [32,33], as a result of the essential role of VHL in regulation of hypoxia-inducible factor 1 (HIF1) levels. This evidence concerns the gene VHL and hereditary clear cell renal cell carcinoma.